Abstract
A highly multidrug-resistant strain of Salmonella enterica serotype Kentucky (S. Kentucky) of sequence type (ST)198 emerged in North Africa and has since spread widely. To investigate the genetic diversity and phylogenetic relationship of S. Kentucky in Zimbabwe and identify potential sources of infection, the whole-genome sequence of 37 S. Kentucky strains isolated from human clinical infections and from poultry farms between 2017 and 2020 was determined. Of 37 S. Kentucky isolates, 36 were ST198 and one was ST152. All ST198 isolates had between six and fifteen antimicrobial resistance (AMR) genes, and 92% carried at least ten AMRs. All ST198 isolates harbored the Salmonella genomic island K-Israel variant (SGI1-KIV) integrated into the chromosome with aac(3)-ld, aac(6)-laa, aadA7, blaTEM-1, sul1, and tetA genes, with occasional sporadic loss of one or more genes noted from five isolates. All ST198 isolates also had mutations in the quinolone resistance-determining region of the gyrA and parC genes. The blaCTX-M-14.1 and fosA3 genes were present in 92% of the ST198 isolates, conferring resistance to extended-spectrum cephalosporins and fosfomycin, respectively, were present on an IncHI2 plasmid with the aadA2b, aadA1, aph(3’)-Ib, aph(6’)-Id, cmlA1 and sul3 AMR genes. S. Kentucky ST198 isolates from Zimbabwe formed a closely related phylogenetic clade that emerged from a previously reported global epidemic population. The close genetic relationship and population structure of the human clinical and poultry isolates of ST198 in Zimbabwe are consistent with poultry being an important source of highly resistant strains of S. Kentucky in Zimbabwe.
Similar content being viewed by others
Introduction
The global spread of antimicrobial-resistant bacteria including high-risk clones has been described as one of the greatest threats facing humankind in the 21st century1, with an estimated 1.27 million deaths per year attributable to bacterial antimicrobial resistance (AMR)2. The prevalence of AMR in low-income countries is generally greater than that in high-income countries3 and poor health care provision in these countries contributes to their vulnerability to infection. Factors leading to the spread of resistance are complex but primarily attributed to the overuse of antibiotics in clinical and agricultural practice4, and response, several national initiatives have been implemented to promote the responsible use of antimicrobials in animal production5. Antibiotics are commonly used therapeutically or as growth promotors in intensive livestock production systems resulting in the emergence of resistant bacteria that can rapidly spread between animals and farms and into the food chain6. Food is one of the most important transmission pathways for AMR pathogens from livestock to humans6, although the direct transfer to farm workers and veterinarians has also been described7. Treatment of human clinical infections with antibiotics may also select for AMR that can transmit to animal populations via sewage8. To combat the threat to human health from antimicrobial resistance, an understanding of the mechanisms of resistance and the drivers of its emergence is needed4.
Non-typhoidal Salmonella (NTS) serotypes are associated with a significant public health burden worldwide. Although commonly a self-limiting gastroenteritis with low case fatality rate and antibiotic treatment is contraindicated, infections resistant to ampicillin, chloramphenicol, streptomycin, sulfonamide, tetracycline, and quinolone antibiotics were associated with increased morbidity and mortality in Denmark9. A severe invasive non-typhoidal Salmonella (iNTS) disease may occur in immunocompromised people due to coinfections or at the extremes of age requiring treatment with antibiotics10. Multidrug-resistant (MDR) strains of Salmonella enterica serotype Typhimurium (S. Typhimurium) and S. Enteritidis are commonly associated with iNTS disease in sub-Saharan Africa11,12,13. There are no specific recommendations for the treatment of iNTS, but in sub-Saharan Africa infections are commonly treated with Fluoroquinolones or extended-spectrum cephalosporins, where available14. The recent emergence of strains resistant to fluoroquinolones due to mutations in the gyrA and parC genes or extended-spectrum cephalosporins through the expression of extended-spectrum beta-lactamase has reduced the treatment options for human infections15,16.
S. Kentucky infections have been commonly linked to the consumption of contaminated poultry globally17 and may acquire resistance particularly easily in response to selection pressure exerted by the use of antibiotics18. S. Kentucky was first isolated from a chicken in the United States of America (USA) in 193719. Although most infections produce mild gastroenteritis, life-threatening disseminated infections are atypically common among elderly and immune-compromised patients compared to other serotypes20. Antimicrobial resistance has been particularly associated with a clone of sequence type (ST) ST198 that emerged in Egypt around the year 1989 and spread across Africa, into Europe, the Middle East and Asia17. Multidrug resistance in ST198 is encoded on Salmonella genomic island 1 (SGI1)21, an integrative mobilizable element that harbors a gene cluster22 conferring resistance to ampicillin, chloramphenicol, streptomycin, sulphonamides, and tetracyclines23. SGI1 with variable gene complement and arrangement such as SGI1K17 and SGI1-KIV24 has been identified in multiple Salmonella serotypes and strains. S. Kentucky ST198 has continued to evolve ever greater resistance, notably to fluoroquinolones then to extended-spectrum cephalosporins. Resistance to fluoroquinolone antibiotics due to mutations in the gyrA and parC genes was first reported in France by a traveler returning from Egypt in 200217,25. Subsequently, 74% of S. Kentucky isolates from 12 countries between 2007 to 2012 were resistant to ciprofloxacin26. Extended-spectrum β-lactamase (ESBL) producing ST198 was originally imported to Europe via travelers returning from North Africa20 and may have been established in some regions of Europe18.
The molecular epidemiology and extent of ESBL-producing S. Kentucky has been reported in several European countries18,27 but remain unknown for Zimbabwe. In this, study, the population structure of isolates recovered from human clinical infections, farm workers, poultry, the poultry farm environment, and poultry feed in Zimbabwe using whole-genome sequencing (WGS) were investigated. Furthermore, we investigated the distribution and genetic flux of AMR determinants of strains identified in Zimbabwe.
Results
S. Kentucky is a common serotype isolated from poultry and human clinical infections in Zimbabwe
To identify S. enterica strains associated with poultry and human clinical infection in Zimbabwe, the whole-genome sequence for 245 non-typhoidal Salmonella strains isolated during routine clinical diagnostics surveillance or from a chicken farm surveillance study, was determined. In silico prediction of serotype using whole-genome sequence revealed a total of 44 distinct serotypes, included 42 S. Enteritidis (17%), 37 S. Kentucky (15%), 22 S. Heidelberg (9%), and 17 S. Typhimurium (6.9%), together accounting for approximately half of all isolates (Supplementary Fig. 1). S. Kentucky represented the most commonly isolated serotype from poultry and farm environment and the fifth most common from human clinical cases of infection. Of 37 S. Kentucky isolated, 11 were from human clinical infections from Harare city (7/11, 64%), and one each from Kadoma, Chitungwiza, Mutare and Chiredzi, from the years 2017 to 2019 (Supplementary Data). Seven cases (64%) were female and four (36%) male, ranging in age from nine months to 76 years, with the majority of cases (55%) in persons under 15 years of age. In all cases, isolation of the bacteria was from stool. Among the 26 isolates from chicken farms, 15 were from chickens, eight from the chicken farm environment, two from farm personnel and one from chicken feed (Supplementary Data).
Phylogenetic relationship and molecular epidemiology of S. Kentucky in Zimbabwe
To investigate the phylogenetic relationship of 37 strains, we first determined the sequence type. A total of 36 strains belonged to ST198 (97.3%) and a single isolate belonged to ST152 (2.7%) (Fig. 1). To investigate the phylogenetic relationship of the isolates from Zimbabwe in the context of fifteen serotypes of Salmonella enterica subspecies I, a maximum likelihood tree was constructed based on sequence variation in the core genome (Fig. 1). All 36 of the ST198 strains isolated in Zimbabwe clustered together in a clade along with the ST198 reference strain 201001922. In contrast, the ST152 strain belonged to a distinct lineage with a similar level of genetic divergence to other serotypes investigated, indicating that ST198 and ST152 acquired the same O-antigens by convergent evolution (Fig. 1). As ST198 is the main sequence type found in Zimbabwe and an epidemic clone of this ST was previously reported17, further analysis was focused on the 36 ST198 strains.
ST198 strains isolated in Zimbabwe from human clinical infection are closely related to poultry isolates
Pairwise comparison of single-nucleotide polymorphisms (SNPs) of the 36 ST198 strains from Zimbabwe indicated a mean root-to-tip distance of ~12 SNPs, consistent with a recent common ancestor (Fig. 2a). The population structure based on shared and unique SNPs indicated three first-order clades, eight second order and ten third-order clades (Fig. 2b). First-order clade 1 comprised three basal-rooted human clinical isolates, clade 2 contained isolates from chickens, the chicken farm environment and farm workers and clade 3 contained human clinical isolates in addition to farm isolates. Several poultry and human isolates differed by fewer than five SNPs, consistent with potential recent transmission events28. However, these were from a different geographical location within Zimbabwe or different years of isolation, consistent with recent spread within Zimbabwe. For example, clade 2.4.4 contained four isolates from chickens, a farm environment, and two farm workers. Isolate ZM19-4 from a chicken had one and two SNPs compared with strains ZM4054 and ZM835, respectively, that were isolated from farm workers. Similarly, a clinical isolate, NM18-63 in clade 3.7.8 differed from the two chicken isolates, ZM75 and ZM1151, by two and five SNPs, respectively (Fig. 2a). Closely related poultry, environmental and human isolates come from different times and geographical locations in Zimbabwe, was consistent with recent spread of the epidemic strain rather than direct transmission. In addition, strain NM17-20 in clade 3.6.5, was isolated from a dining table in Marondera and was identical to three human clinical isolates from Harare in the same year, suggesting contamination from a shared source (Fig. 2b). The population structure is also consistent with inter-farm transmission of S. Kentucky, as evidenced by four identical strains in clade 3.8.10 that originated from chickens on farms in Nyabira, Marondera, and Mt Hampden (Fig. 2b).
S . Kentucky ST198 from Zimbabwe encode resistance to a broad range of antimicrobials
All ST198 strains isolated in Zimbabwe contained at least six AMR genes, and 92% contained a total of between ten and fifteen AMR genes. Most strains (86%) had an aadA7, blaTEM-1, sul1, and tetA gene known to be associated with SGI-1 in S. Kentucky ST198 strains17 and 92% also had aadA, aph(6)-ld, blaCTX-M-14.1, cml, fosA3, and sul3 genes. Together these AMR genes were predicted to confer resistance to diverse classes of antibiotics including aminoglycosides, β-lactams, fosfomycin, phenicol, quinolones, sulphonamides, and tetracycline. In addition, fluoroquinolone resistance was due to point mutations in the chromosomal genes gyrA and parC (Fig. 2b).
A wide range of plasmid replicons were present in both clinical and poultry farm strains, of which ColpVC and IncHI2/ IncHI2A were the most abundant (36/36 or 100% and 33/36 or 92% isolates, respectively). The presence of the aadA, aph(6)-ld, blaCTX-M-14.1, cml, fosA3, and sul3 in 92% of strains coincided with the presence of an IncHI2 origin of replication. The presence of these resistance genes in deeply rooted lineages was consistent with their acquisition by a common ancestor of ST198 strains from Zimbabwe and occasional sporadic loss of between one and eight genes in three strains (ZM19-82, ZM-46, and NM17-56) (Fig. 2b).
Strain NM17-56 contained a blaCMY-2 gene that coincided with the presence of an IncI plasmid origin of replication. Strain ZM1151 contained the qnrB gene conferring decreased susceptibility to fluoroquinolone antibiotics that was also the only strain in this collection that did not have mutations in the gyrA gene which is associated with resistance to these antibiotics. Finally, strain ZM20 had the dfrA14 and sul2 genes that was not accompanied by additional plasmid replicons in available databases (Fig. 2b).
Antimicrobial resistance is associated with plasmids and an integrative mobilizable element SGI1 in the Zimbabwe S. Kentucky ST198
To further investigate the co-occurrence of IncHI2 replicon genes with aadA, aph(6), blaCTX-M-14.1, cml, fosA3, and sul3 AMR genes and an IncI plasmid carrying the blaCMY gene, the complete and closed whole-genome sequence of strains NM17-19 and NM17-56 was determined using long-read sequencing. A contiguous assembled sequence of approximately 157 kb containing an IncHI2 replicon (PTU-HI2) and the aadA, aph(6)-ld, blaCTX-M-14.1, cml, fosA3 and sul3 resistance genes, present on a composite transposon was identified and designated pGTZIM1 (Fig. 3). Alignment of the sequence to the PLSDB plasmid database indicated that a plasmid pF218CHI2 (accession NZ_CP043545.1) from an E. coli strain as the closest known relative. Plasmid pF2_18C_HI2 also carried the aadA, aph(6), cml and sul3 resistance genes found in plasmid pGTZIM1, but lacked the blaCTX-M-14.1 and fosA3 genes. The blaCTX-M gene present in pF2_18C_HI2 differed from blaCTX-M-14.1 by a non-synonymous mutation resulting in a predicted I17F substitution in the primary amino acid sequence (Supplementary Fig. 2).
A second contiguous assembled sequence of 92.5 kb from NM17-56 contained an IncI replicon (PTU-I1) and carried a blaCMY gene and was designated pGTZIM2 (Fig. 4). Alignment of the sequence to the PLSDB plasmid database indicated that plasmid p92 (RefSeq NZ_023376.1) first identified in an E. coli strain was the closest known relative. Three other plasmids from S. Kentucky strains in the database were also close relatives, sharing the same backbone, but only one had a blaCMY gene (GCA_006339875.2), a second carried the tetC, tet, and tetR tetracycline resistance genes (GCA_011480175.2), while the third lacked resistance genes (GCA_007862665.2). The long-read assembly of both NM17-19 and NM17-56 revealed the presence of a 3.3 kb ColpVC plasmid (PTU-E1), which also shares similarities with an E. coli plasmid (pCFS3313-4, RefSeq accession number NZ_CP053654.1), that we designated pGTZIM3 (Supplementary Fig. 3). Alignment of the sequence to available databases failed to identify known AMR or virulence genes in pGTZIM3.
ST198 from Zimbabwe carry SGI1-KIV
Mapping of short-read sequence of S. Kentucky ST198 strains from Zimbabwe to SGI-1K (accession AY463797.8) indicated the presence of an SGI1-K-like element. Most isolates had >98% coverage of SGI-1K and the remaining six had greater than 73% coverage with various potential deletions (Fig. 2b). Alignment of the long-read genome assemblies of NM17-19 and NM17-56 revealed a genomic structure of SGI1 different from the canonical SGI1-K and identical to a previously reported SGI1K variant, designated SGI1-KIV (SGI1-K Israeli Version, Fig. 5)24. Unlike SGI1-K which is present as a single contiguous insertion in the trmE/ydiY locus, SGI1-KIV was present in two sections inserted into the rbsK locus and trmE/ydiY loci separated by 50 kb of the core genome sequence. Furthermore, SGI1-KIV lacked the aph(6’) and aph(3’) resistance genes present on the canonical SGI1-K, although in strains NM17-19 from Zimbabwe, the aph(6’) and aph(3’) were present on the IncHI2 plasmid pGTZIM1 (Fig. 5).
ST198 strains from Zimbabwe are part of an internationally dispersed MDR clone
The phylogenetic relationship of 36 S. Kentucky ST198 strains isolated in Zimbabwe were investigated in the context of 364 ST198 strains isolated in 33 countries on five continents between 1937 and 2020. A maximum likelihood phylogenetic tree constructed based on recombination-purged sequence variation in the core genome revealed a population structure with multiple deeply rooted clades (Fig. 6a). Most of the deeply rooted branches consisted of a single isolate on long extended branches that were predominantly isolated from the US or Southern and East Asia (gray lineages in Fig. 6). A single deeply rooted lineage gave rise to a clade containing the majority of S. Kentucky ST198 strains. This large clade contained strains isolated from many countries worldwide, but strains present in a basal clade and therefore most closely related to the hypothetical ancestor were predominantly from Egypt. ST198 strains isolated in Zimbabwe formed a distinct subclade that was nonetheless closely related to consisting of 29 closely related ST198 strains from UK (33 strains), India (5 strains), Denmark (2 strains), Pakistan (1 strain), Netherlands (1 strain), US (1 strain) and Belgium (1 strain) (Fig. 6b). However, 25 of the strains isolated in the UK were associated with travel to India or Pakistan, while travel information for six isolates was not known. Therefore 31 of 45 (68%) of strains were isolated from or known to be associated with travel to South Asian Countries, implicating spread from these countries to Zimbabwe. A S. Kentucky ST198 strain isolated in Israel in which SGI1-KIV was first reported was present in a more deeply rooted clade than the Zimbabwe clade (Fig. 6a).
Determination of the presence of AMR genes in the global collection of S. Kentucky ST198 indicated that isolates from Zimbabwe contained more AMR genes in part due to the acquisition of pGTZIM1 (Supplementary Fig. 4, Fig. 6b, and Supplementary Data). The aadA7, blaTEM-1, sul1 and tetA genes, commonly associated with SGI1, were present in most ST198 strains from the global collection, consistent with its acquisition immediately prior to clonal expansion and spread as previously reported. In contrast, the aph(6), blaCTXM-14.1, cml, fosA3, and sul3 genes present in the majority of ST198 strains from Zimbabwe on the IncHI2 plasmid pGTZIM1, were generally absent from strains isolated from elsewhere, consistent with recent acquisition potentially within Zimbabwe or an unsampled population giving rise to the Zimbabwe subclade. Sporadic distribution of a subset of aph(6), blaCTXM-14.1, cml, fosA3, or sul3 genes were present in individual strains or clusters of strains isolated from outside of Zimbabwe, and all but three of strains lacked an IncHI2 origin of replication. Conversely, three strains isolated from outside of Zimbabwe had the IncHI2 origin of replication and at least one of the aph(6), blaCTXM-14.1, cml, or sul3 genes while six had none of these genes.
Discussion
Diverse NTS serotypes were isolated through routine surveillance of human clinical infections and poultry-associated sources between 2016 and 2020 in Zimbabwe. A total of 45 different serotypes were represented among 245 isolates. Overall, S. Kentucky was the second most frequently isolated serotype, representing 15.1% (37/245) of the total isolates. Over-representation of poultry-associated sources in this study is likely to have contributed to elevating the frequency of isolation of the S. Kentucky that is particularly common in this host species29. Nonetheless, S. Kentucky was the 5th most frequently isolated serotype from human clinical infection in this strain collection from Zimbabwe and is therefore a serotype of significant concern to public health. With the notable exception of invasive disease where S. Typhimurium and S. Enteritidis dominate, few studies have reported the relative frequency of NTS serotypes in clinical infection or from livestock in sub-Saharan Africa and S. Kentucky has not been reported as common10. S. Kentucky was reported as relatively common in gastroenteritis NTS infections in North Africa and the Middle East30. This study is therefore the first to report WGS analysis of ESBL-producing S. Kentucky strains of human and poultry origin in Sub-Saharan Africa.
All but one of the NTS strains from Zimbabwe investigated in this study belonged to ST198, with a single strain belonging to ST152. The presence of these sequence types on distinct long basally rooted lineages in the population structure of S. enterica subspecies I indicated that the serotype is polyphyletic, with the antigens used to define serotypes emerging independently as observed for some serotypes such as S. Derby and S. Paratyphi B31,32. The low number of SNPs within the ST198 cluster was consistent with a recent common ancestor within the past decade based on published molecular clock rates of ~1–2 SNPs per genome per year for Salmonella epidemic clades12,33,34. This lack of genetic diversity and wide geographical distribution within Zimbabwe suggests that the clone has spread rapidly to many farms across the country. The presence of strains of S. Kentucky ST198 in feed that were closely related to strains isolated from poultry implicates this as a potential source of transmission. Nonetheless, the relative contribution of livestock transfer, other animal species or environmental factors and feed in the transmission of S. Kentucky ST198 between farms in Zimbabwe cannot be assessed with these data. The close genetic distance between isolates are also consistent transmission of S. Kentucky from poultry to humans, but due to a small dataset and the limitation of sampling, no case of direct transmission could be inferred with high confidence.
Strains isolated in Zimbabwe formed a distinct clade within a globally dispersed ST198 population that emerged in Egypt in 1989 and was associated with multidrug resistance conferred by the acquisition of SGI-1 and resistance to fluoroquinolones due to mutations in the gyrA and parC genes17,35,36,37,38,39,40,41,42. The Zimbabwe clade was distally rooted within the phylogeny of globally sourced strains of ST198, suggesting that this clone spread to Zimbabwe later than those in other countries represented in the global collection. Consistent with this idea, all the Zimbabwe strains contained resistance genes present in SGI-1 and mutation substitutions in the gyrA and parC genes known to confer resistance to ciprofloxacin36.
The prevalence of ESBL-producing S. Kentucky in Zimbabwe is concerning as extended-spectrum cephalosporins are currently the first-line antimicrobials for the empiric therapy of acute salmonellosis43. Furthermore, resistance of these strains to other therapeutic options including chloramphenicol and fluoroquinolones, leaves limited options for clinical management of severe infections. Our data were consistent with a distinct origin of an ESBL gene in Zimbabwe, unrelated to recent emergence of other ESBL genes in S. Kentucky DST198 in Europe and China. Similar blaCTX-M genes to that identified in the Zimbabwe isolates reported previously were present in phylogenetically distinct clades and in a different genomic context. Most ESBL-producing strains from outside of Zimbabwe were associated with the blaCTX-M-14b gene that differ from blaCTX-M-14.1 gene of some Zimbabwe isolates by a single amino acid substitution (I17F). The European center for disease control and prevention (ECDC) recently launched an Urgent Inquiry (UI-464) on a ciprofloxacin-resistant ST198 strain carrying a blaCTX-M-14b gene conferring cephalosporin resistance integrated adjacent to the hcp1 gene on the chromosome18. This MDR clone of S. Kentucky ST198 is already widespread and has been declared a high-risk global MDR clone17. The strain spread to several EU countries18,27 but to date has only been reported in human infections18. In contrast, in China and ST198 clone carrying a chromosomally integrated blaCTX-M-14b gene was isolated from a poultry slaughterhouse44. A second chromosomally encoded gene blaVEB-8 was identified in a S. Kentucky ST19827 and blaCTX-M-15 and blaCMY genes carried on plasmids have also been reported in S. Kentucky ST198 isolates from Europe27,28. Further plasmid-mediated antibiotic resistance is concerning as plasmids may be more easily acquired during bacterial evolution, but may also be easily lost45.
A limitation of this study was the relatively small sample size of 37 S. Kentucky isolates analyzed. However, it already demonstrated the role that animals and humans in Zimbabwe play in the circulation of this emerging antimicrobial-resistant enteric pathogen. As far as we are aware this is the first study originating from Africa reporting on the presence of the epidemic ciprofloxacin-resistant ST198 with a novel ESBL blaCTX-M-14.1 gene located on an IncHI2 plasmid. Zimbabwe strains of ST198 exhibited a considerable increase in the number of genes from a median of nine to 18 AMR genes and conferring additional resistance to phenicols, phosphonic and extended-spectrum β-lactam antibiotics compared to MDR S. Kentucky reported previously17,18. The resistance profile is comparable to that described previously as extensively-drug resistance (XDR) in S. Typhi46 and has potentially significant implications to the clinical management of severe infections. The spread of ESBL-producing Salmonella serotypes is of great concern in many countries and the CTX-M family is the most common globally disseminated gene in a broad spectrum of microbial species47. The data highlight the need of an increased surveillance incorporating genomic epidemiology of NTS in both human and animal populations through a One Health approach. The information generated by continuous monitoring can be fed into policies and intervention to prevent the spread of this highly resistant clone and prevent the emergence of new ones.
Methods
Bacterial isolates used in this study
A total of 245 NTS strains isolated during routine surveillance by the National Microbiology Reference Laboratory of Zimbabwe were investigated in this study. Strains were isolated from human clinical infections (n = 162) during the period 2016 to 2020, chicken farms (n = 82) isolated from the years 2018 to 2020, crocodile meat (n = 1) and a dining table at a school (n = 1). The human Salmonella isolates (n = 162) were from stool (157/162) and blood samples (5/162) from clinical cases received from the National Salmonella Surveillance sentinel sites. Chicken farm isolates (n = 82) originated from chicken (n = 30), boot swab (n = 1), environmental swabs (n = 34), rectal swabs from asymptomatic farm workers (n = 10), litter (n = 1), and chicken feed pellet (n = 6) samples. Ethics approval for the study was granted by the University of Pretoria, South Africa (779/2018) and the Medical Research Council of Zimbabwe (MRCZ/A/2369). Strains are available upon request subject to requirements of the Nagoya Protocol.
Salmonella isolation, serotyping, and antimicrobial susceptibility testing
Salmonella isolation, serotyping based on the Kauffmann–White–Le Minor scheme according to ISO 6579-1:201748. Briefly, the test strain was cultured on Mueller Hinton (MH) agar and 2–3 colonies were suspended in sterile 0.45% saline on a glass slide. Antiserum (Mast, UK) was added and agglutination monitored for two minutes on a rocking plate. A control without antiserum was used to test for autoagglutination. Serotype was determined based in antigenic formula49. Antimicrobial susceptibility testing results using Kirby-Bauer disc diffusion assays were used as described previously50. Briefly, 4–5 colonies were resuspended in sterile 0.45% saline, turbidity adjusted to a 0.5 McFarland standard and inoculated onto MH agar with a swab. Antimicrobial discs impregnated with antimicrobial (Mast, UK) were placed on the surface and incubated at 35 °C for 18 h. The panel of antimicrobials tested comprised: ciprofloxacin (5 μg), ceftriaxone (30 μg), chloramphenicol (30 μg), tetracycline (30 μg), azithromycin (15 µg), ertapenem (10 µg), ampicillin (10 μg), ceftazidime (30 μg), ceftazidime + clavulanic acid (30 μg/10 μg), cefotaxime (30 μg), and cefotaxime + clavulanic acid (30 μg/10 μg) (Oxoid, UK). Escherichia coli ATCC 25922 was used as internal quality control. Results were interpreted using the Clinical and Laboratory Standards Institute (CLSI M100, 30th Edition) antimicrobial susceptibility testing standard (2020) included in WHONET 5.6 version software51.
Whole-genome sequencing (WGS) and quality control
A volume of 1 mL of an overnight Salmonella culture in Tryptone Soy Broth (Oxiod, Hampshire, UK) was harvested by centrifugation for 2 min at 13,000 × g (ThermoScientific, Germany). Genomic DNA was extracted from the 245 Salmonella isolates using a Maxwell® RSC 48 automated nucleic acid purification instrument (Madison, Wisconsin, USA). The DNA concentration was measured with a Qubit fluorometer (Life Technologies, Carlsbad, CA, USA) and adjusted to 0.2 ng/µL, and stored at –20 °C before library preparation. The library preparation for short-read sequencing, was performed using the Nextera Flex DNA Library Preparation Kit according to the manufacturer’s instructions (Illumina, San Diego, CA, USA). Subsequently, sequencing was performed with a NextSeq benchtop sequencer (Illumina, San Diego, CA, USA). Raw sequence data were submitted to the Sequence Read Archive (SRA) (https://www.ncbi.nlm.nih.gov/sra) under study accession PRJNA762287. Read quality was assessed with fastp52 and summarized with multiqc53. Sequences with a theoretical read depth below 20x, or with less than 80% of reads attributed to Salmonella using Bracken were excluded from further analysis. Only samples that passed the quality control were considered for genomic analysis.
Freshly extracted DNA, for long-read sequencing, was ligated using native barcoding SQK-LSK109 following ONT recommendations. The library pool was loaded on a MinION Flow Cell (R9.4.1) at 43 fmol. The raw reads are available in the Sequence Read Archive (SRA) (accession PRJNA762287).
Illumina short-read sequence analysis and assembly
The serotype formula 245 S. enterica strains isolated in Zimbabwe that passed the quality control were identified from short-read sequence data using SeqSero254. Multilocus sequence type (MLST) for Salmonella enterica, the presence of antimicrobial resistance genes and plasmid replicon incompatibility group were identified in raw sequence reads using ARIBA55 with the ResFinder database56 or the plasmidfinder database57, with default settings. Raw sequence reads were assembled using SPAdes version 3.13.058 and chromosomal point mutations in gyrA, gyrB, parC, and parE genes identified using RGI59. For phylogenetic analysis S. enterica strains isolated in Zimbabwe or 364 S. Kentucky ST198 genomes previously described17,18,24,44, raw sequence data were mapped to the reference genome strain 201001922 (GenBank accession number CP028357) using snippy version 4.1.0 (https://github.com/tseemann/snippy) with parameters (--mapqual 60 –basequal 13 –mincov 4 –minfrac 0.75) to identify single-nucleotide polymorphism (SNPs). Putative recombinogenic regions were detected based on SNP density and masked using Gubbins version 2.2.060 with default settings. A maximum likelihood (ML) phylogenetic tree was built from an alignment of chromosomal SNPs, with RAxML61 version 8.2.8 using the GTR model with bootstraps as determined by the auto-mre flag. The tree visualized with ggtree62. HierBaps63 was used to estimate the population structure with a max depth of 3 and n.pops of 10. To investigate conservation of SGI1K using short-read data, reads were mapped to the SGI1K reference (genbank accession AY463797.8) using minimap264 and the percentage of sequence covered assessed using bedtools65. The presence of individual SGI1K genes was assessed using ARIBA55.
Long-read assembly and sequence analysis
Long-read data was assembled using trycycler66. The reads were filtered using filtlong (keep 95%, minimum length 1 kb) 12 subsamples of reads were generated, and assemblies generated using either flye, raven, or miniasm (four assemblies per software). Trycycler reconcile, and consensus was used to generate a consensus assembly. Pilon was used correct sequencing errors with matched Illumina short-read data, the quality of the polished assembly was assessed with QUAST67 and Socru68 was used to confirm the orientation of the chromosome fragments. The start of the chromosome was set to thrL using circlator69. BLAST was also used to compare SGI1-K to the genome assembly, and comparison of chromosomal and plasmids region of interest were visualized using genoplotR70. Plasmid taxonomic unit was identified using COPLA71 and compared against the plasmid database (PLSDB)72 using BLAST to identify closely related plasmids.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
Sequence data reported for the first time in this study have been deposited in Sequence Read Archive (SRA) (accession PRJNA762287). All other sequence data used in the analysis are in available databases accessible using accession number (Supplementary Data).
Code availability
All software used in the sequence analysis is freely available from repositories described in the cited literature.
References
Anonymous. Tackling drug resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (2016).
Antimicrobial Resistance C. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
Klein, E. Y. et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc. Natl Acad. Sci. USA 115, E3463–E70. (2018).
Holmes, A. H. et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387, 176–187 (2016).
Cuong, N. V., Padungtod, P., Thwaites, G. & Carrique-Mas, J. J. Antimicrobial usage in animal production: a review of the literature with a focus on low- and middle-income countries. Antibiotics 7, 75 (2018).
Wall, B. A. et al. Drivers, Dynamics and Epidemiology of Antimicrobial Resistance in Animal Production (Food and Agriculture Organization of the United Nations, 2016).
Marshall, B. M. & Levy, S. B. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 24, 718–733 (2011).
Mather, A. E. et al. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 341, 1514–1517 (2013).
Helms, M., Vastrup, P., Gerner-Smidt, P. & Molbak, K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg. Infect. Dis. 8, 490–495 (2002).
Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S. & Gordon, M. A. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379, 2489–2499 (2012).
Kingsley, R. A. et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res. 19, 2279–2287 (2009).
Okoro, C. K. et al. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat. Genet. 44, 1215–1221 (2012).
Feasey, N. A. et al. Distinct Salmonella enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings. Nat. Genet. 48, 1211–1217 (2016).
Kariuki, S., Gordon, M. A., Feasey, N. & Parry, C. M. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine 33, C21–C29 (2015).
Boyle, F. et al. First report of extended-spectrum-beta-lactamase-producing Salmonella enterica serovar Kentucky isolated from poultry in Ireland. Antimicrob. Agents Chemother. 54, 551–553 (2010).
Hedberg, C. W. Challenges and opportunities to identifying and controlling the international spread of salmonella. J. Infect. Dis. 204, 665–666 (2011).
Hawkey, J. et al. Global phylogenomics of multidrug-resistant Salmonella enterica serotype Kentucky ST198. Microb. Genom. 5, e000269 (2019).
Coipan, C. E. et al. Genomic epidemiology of emerging ESBL-producing Salmonella Kentucky bla (CTX-M-14b) in Europe. Emerg. Microbes. Infect. 9, 2124–2135 (2020).
Edwards, P. R. A new Salmonella type: Salmonella Kentucky. J. Hyg. 38, 306–308 (1938).
Le Hello, S. et al. International spread of an epidemic population of Salmonella enterica serotype Kentucky ST198 resistant to ciprofloxacin. J. Infect. Dis. 204, 675–684 (2011).
Doublet, B. et al. Novel insertion sequence- and transposon-mediated genetic rearrangements in genomic island SGI1 of Salmonella enterica serovar Kentucky. Antimicrob. Agents Chemother. 52, 3745–3754 (2008).
Boyd, D. et al. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J. Bacteriol. 183, 5725–5732 (2001).
Mulvey, M. R., Boyd, D. A., Olson, A. B., Doublet, B. & Cloeckaert, A. The genetics of Salmonella genomic island 1. Microbes. Infect. 8, 1915–1922 (2006).
Cohen, E. et al. Emergence of new variants of antibiotic resistance genomic islands among multidrug-resistant Salmonella enterica in poultry. Environ. Microbiol. 22, 413–432 (2020).
Weill, F. X. et al. Ciprofloxacin-resistant Salmonella Kentucky in travelers. Emerg. Infect. Dis. 12, 1611–1612 (2006).
Westrell, T., Monnet, D. L., Gossner, C., Heuer, O. & Takkinen, J. Drug-resistant Salmonella enterica serotype Kentucky in Europe. Lancet Infect. Dis. 14, 270–271 (2014).
Biggel, M., Horlbog, J., Nuesch-Inderbinen, M., Chattaway, M. A. & Stephan R. Epidemiological links and antimicrobial resistance of clinical Salmonella enterica ST198 isolates: a nationwide microbial population genomic study in Switzerland. Microb. Genom. 8, 000877 (2022).
Coipan, C. E. et al. Concordance of SNP- and allele-based typing workflows in the context of a large-scale international Salmonella enteritidis outbreak investigation. Microb. Genom. 6, e000318 (2020).
Haley, B. J. et al. Genomic and evolutionary analysis of two Salmonella enterica Serovar Kentucky sequence types isolated from bovine and poultry sources in North America. PLoS ONE 11, e0161225 (2016).
Hendriksen, R. S. et al. Global monitoring of Salmonella serovar distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank: results of quality assured laboratories from 2001 to 2007. Foodborne Pathog. Dis. 8, 887–900 (2011).
Sevellec, Y. et al. Polyphyletic nature of Salmonella enterica Serotype Derby and lineage-specific host-association revealed by genome-wide analysis. Front Microbiol 9, 891 (2018).
Connor, T. R. et al. What’s in a name? Species-wide whole-genome sequencing resolves invasive and noninvasive lineages of Salmonella enterica Serotype Paratyphi B. mBio 7, e00527–16 (2016).
Hawkey, J. et al. Evidence of microevolution of Salmonella Typhimurium during a series of egg-associated outbreaks linked to a single chicken farm. BMC Genom. 14, 800 (2013).
Tassinari, E. et al. Whole-genome epidemiology links phage-mediated acquisition of a virulence gene to the clonal expansion of a pandemic Salmonella enterica serovar Typhimurium clone. Microbial. Genom. 6, mgen000456 (2020).
Xiong, Z. et al. Ciprofloxacin-resistant Salmonella enterica Serovar Kentucky ST198 in broiler chicken supply chain and patients, China, 2010–2016. Microorganisms 8, 140 (2020).
Haley, B. J. et al. Salmonella enterica serovar Kentucky recovered from human clinical cases in Maryland, USA (2011–2015). Zoonoses Public Health 66, 382–392 (2019).
Ramadan, H. et al. Draft genome sequences of two ciprofloxacin-resistant Salmonella enterica subsp. enterica serotype Kentucky ST198 isolated from retail chicken carcasses in Egypt. J. Glob. Antimicrob. Resist. 14, 101–103 (2018).
Le Hello, S. et al. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect. Dis. 13, 672–679 (2013).
Park, A. K. et al. Traveller-associated high-level ciprofloxacin-resistant Salmonella enterica Serovar Kentucky in the Republic of Korea. J. Glob. Antimicrob. Resist. 22, 190–194 (2020).
Mahindroo, J. et al. Endemic fluoroquinolone-resistant Salmonella enterica serovar Kentucky ST198 in northern India. Microb. Genom. 5, e000275 (2019).
Ktari, S. et al. Carbapenemase-producing Salmonella enterica serotype Kentucky ST198, North Africa. J. Antimicrob. Chemother. 70, 3405–3407 (2015).
Moon, D. C., Yoon, S. S. & Lim, S. K. Complete genome sequence of a ciprofloxacin-resistant Salmonella Kentucky ST198 strain from a chicken carcass in South Korea. J. Glob. Antimicrob. Resist. 24, 373–375 (2021).
Stoycheva, M. V. & Murdjeva, M. A. Antimicrobial therapy of salmonelloses–current state and perspectives. Folia Med. 48, 5–10 (2006).
Lei, C. W., Zhang, Y., Wang, X. C., Gao, Y. F. & Wang, H. N. Draft genome sequence of a multidrug-resistant Salmonella enterica serotype Kentucky ST198 with chromosomal integration of bla(CTX-M-14b) isolated from a poultry slaughterhouse in China. J. Glob. Antimicrob. Resist. 20, 145–146 (2020).
De Gelder, L., Ponciano, J. M., Joyce, P. & Top, E. M. Stability of a promiscuous plasmid in different hosts: no guarantee for a long-term relationship. Microbiology 153, 452–463 (2007).
Klemm, E. J. et al. Emergence of an extensively drug-resistant Salmonella enterica Serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. mBio 9, e00105-18 (2018).
Canton, R., Gonzalez-Alba, J. M. & Galan, J. C. CTX-M enzymes: origin and diffusion. Front. Microbiol. 3, 110 (2012).
Anonymous. Microbiology of the food chain—horizontal method for the detection, enumeration and serotyping of Salmonella—Part 1: Detection of Salmonella spp. ISO 6579-1:2017 2017. https://www.iso.org/standard/56712.html (2019).
Grimont, P. A. D. & Weill, F. X. Antigenic Formulae of the Salmonella Serovars. 9th Edition, World Health Organization Collaborating Center for Reference and Research on Salmonella, (Institut Pasteur, Paris, 2007).
Hudzicki, J. Kirby-Bauer disk diffusion susceptibility test protocol. Am. Soc. Microbiol. 55, 55–63 (2009).
Agarwal, A., Kapila, K. & Kumar, S. WHONET software for the surveillance of antimicrobial susceptibility. Med. J. Armed Forces India 65, 264–266 (2009).
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
Ewels, P., Magnusson, M., Lundin, S. & Kaller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 32, 3047–3048 (2016).
Zhang, S. et al. SeqSero2: rapid and improved Salmonella serotype determination using whole-genome sequencing data. Appl. Environ. Microbiol. 85, e01746-19 (2019).
Hunt, M. et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microbial. Genom. 3, e000131 (2017).
Zankari, E. et al. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67, 2640–2644 (2012).
Carattoli, A. Plasmid-mediated antimicrobial resistance in Salmonella enterica. Curr. Issues Mol. Biol. 5, 113–122 (2003).
Prjibelski, A., Antipov, D., Meleshko, D., Lapidus, A. & Korobeynikov, A. Using SPAdes de novo assembler. Curr. Protoc. Bioinforma. 70, e102 (2020).
Alcock, B. P. et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48, D517–D525 (2020).
Croucher, N. J. et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 43, e15 (2015).
Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
Yu, G., Smith, D. K., Zhu, H., Guan, Y. & Lam, T. T. Y. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28–36 (2017).
Cheng, L., Connor, T. R., Siren, J., Aanensen, D. M. & Corander, J. Hierarchical and spatially explicit clustering of DNA sequences with BAPS software. Mol. Biol. Evol. 30, 1224–1228 (2013).
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
Quinlan, A. R. BEDTools: the Swiss‐army tool for genome feature analysis. Curr. Protoc. Bioinforma. 47, 11.12.1-34 (2014).
Wick, R. R. et al. Trycycler: consensus long-read assemblies for bacterial genomes. Genome Biol. 22, 266 (2021).
Gurevich, A., Saveliev, V., Vyahhi, N. & Tesler, G. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29, 1072–1075 (2013).
Page, A. J., Ainsworth, E. V. & Langridge, G. C. socru: typing of genome-level order and orientation around ribosomal operons in bacteria. Microb. Genom. 6, mgen000396 (2020).
Hunt, M. et al. Circlator: automated circularization of genome assemblies using long sequencing reads. Genome Biol. 16, 294 (2015).
Guy, L., Roat Kultima, J. & Andersson, S. G. genoPlotR: comparative gene and genome visualization in R. Bioinformatics 26, 2334–2335 (2010).
Redondo-Salvo, S. et al. COPLA, a taxonomic classifier of plasmids. BMC Bioinforma. 22, 390 (2021).
Galata, V., Fehlmann, T., Backes, C. & Keller, A. PLSDB: a resource of complete bacterial plasmids. Nucleic Acids Res. 47, D195–D202 (2019).
Acknowledgements
We thank the entire network of the One Health AMR Surveillance laboratories, especially National Microbiology Reference Laboratory and Central Veterinary Laboratory for providing the isolates and the core sequencing team at the Quadram Institute Bioscience. We also thank Muzhuzha Marclay C., Tamika Munetsi and Mafuka Paidamwoyo V. for helping in culturing the strains isolated in Zimbabwe. RK and GT were supported by BBSRC Institute Strategic Programme Microbes in the Food Chain BB/R012504/1 and its constituent projects BBS/E/F/000PR10348 and BBS/E/F/000PR10349.
Author information
Authors and Affiliations
Contributions
T.M., G.T., R.A.K., and M.M.E. designed the study. T.M., G.T., B.V.C., P.L., M.N., V.R., H.A.K., D.B., M.G., S.M., M.L.W., M.J., and J.D.J. acquired the data. G.T., T.M., and M.B. carried out data analysis and visualization. G.T., T.M., M.M.K., F.M.A., F.X.W., R.S.H., M.M.E., and R.A.K. interpreted the analysis. G.T., T.M., and R.A.K. drafted the manuscript. All authors critically reviewed the manuscript and approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
M.N. and M.G. are employed by Irvine’s Harare, Zimbabwe. T.M., G.T., B.V.C., P.L., M.B., V.R., A.T., H.A., D.B., M.M.K., S.M., M.L.W., M.J., J.D.J., F.M.A., F.X.W., R.S.H., M.M.E., and R.A.K. have no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mashe, T., Thilliez, G., Chaibva, B.V. et al. Highly drug resistant clone of Salmonella Kentucky ST198 in clinical infections and poultry in Zimbabwe. npj Antimicrob Resist 1, 6 (2023). https://doi.org/10.1038/s44259-023-00003-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s44259-023-00003-6